Vincent Meunier

Stock Analyst at Morgan Stanley

(1.02)
# 3,830
Out of 5,072 analysts
9
Total ratings
33.33%
Success rate
-4.48%
Average return
Main Sectors:

Stocks Rated by Vincent Meunier

Novartis AG
Sep 25, 2023
Upgrades: Equal-Weight
Price Target: n/a
Current: $130.44
Upside: -
Novo Nordisk
Dec 14, 2018
Initiates: Equal-Weight
Price Target: n/a
Current: $48.71
Upside: -